Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | Executive VP RA, QA | March 02, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date March 02, 2026 · Filed March 18, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2036-03-02 | Direct | 17,198 |
Reported balance
After 2026-03-02 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-03-02 · Grant · Acquired 17,198 · Balance 17,198 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. F2: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,554 shares for a total of 17,198 RSUs granted. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
F2: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,554 shares for a total of 17,198 RSUs granted.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2026 Filed Mar 10, 2026 18:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRSUs (Restricted Stock Units) · Derivative | 75 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000029 · form4.xml · derivative · entry 3 Lalomia Brent · CIK 0001921560 · Executive VP RA, QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75 shares Expires 2032-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each RSU represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 18:40 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 26 | $39.90 | $1,037.40 |
DisclosureSEC source: 0000816956-26-000029 · form4.xml · nonDerivative · entry 2 Lalomia Brent · CIK 0001921560 · Executive VP RA, QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 915.057 Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 18:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000029 · form4.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Executive VP RA, QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 941.057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The number of shares beneficially owned by the reporting person has been adjusted to exclude 140 shares that were incorrectly reflected in prior reports. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 20:54 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 11,322 | $0.00 Strike: $45.79 | $0.00 |
DisclosureSEC source: 0000816956-26-000019 · form4.xml · derivative · entry 2 Lalomia Brent · CIK 0001921560 · Executive VP RA, QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,322 Underlying: Common Stock · 11,322 shares Expires 2036-03-02 F2 · derivative.exercise_date: The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 20:54 UTC | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 9,554 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000019 · form4.xml · derivative · entry 1 Lalomia Brent · CIK 0001921560 · Executive VP RA, QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,554 Underlying: Common Stock · 9,554 shares Expires 2036-03-02 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. Read SEC document |
| March 02, 2026 Filed Mar 18, 2026 18:07 UTC Amendment | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 17,198 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000039 · form4a.xml · derivative · entry 1 Lalomia Brent · CIK 0001921560 · Executive VP RA, QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,198 Underlying: Common Stock · 17,198 shares Expires 2036-03-02 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. F2 · derivative.underlying_shares: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,554 shares for a total of 17,198 RSUs granted. Read SEC document |
| December 31, 2025 Filed Jan 8, 2026 16:29 UTC | CONMED Corp CNMD · Entity 4691 | OtherCommon Stock | 31.626 | $40.60 | $1,284.02 |
DisclosureSEC source: 0000816956-26-000002 · form5.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Executive VP RA, QA 10b5-1 filing: No plan indicated Ownership: Indirect · 401 (K) Plan Disclosed balance after: 125.232 F1 · date: As of December 31, 2025. F2 · balance_after: Between January 1, 2025 and December 31, 2025, the reporting person acquired 31.626 shares of CNMD common stock under the CNMD 401(k) plan. The information in this report is based on a plan statement dated as of December 31, 2025. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 18:27 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRSUs (Restricted Stock Units) · Derivative | 75 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-009019 · form4.xml · derivative · entry 3 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75 Underlying: Common Stock · 75 shares Expires 2032-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 18:27 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 26 | $62.74 | $1,631.24 |
DisclosureSEC source: 0001127602-25-009019 · form4.xml · nonDerivative · entry 2 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,006.057 Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 18:27 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-009019 · form4.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,032.057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 20:40 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 26,895 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001127602-25-008269 · form4.xml · derivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,895 Underlying: Common Stock · 26,895 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| December 31, 2024 Filed Apr 7, 2025 17:07 UTC | CONMED Corp CNMD · Entity 4691 | Other401 (K) Plan | 22.993 | $68.44 | $1,573.64 |
DisclosureSEC source: 0001127602-25-011741 · form5.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Executive VP RA, QA 10b5-1 filing: No plan indicated Ownership: Indirect · 401 (K) Plan Disclosed balance after: 93.606 F1 · date: As of December 31, 2024. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 15:44 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 75 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009313 · form4.xml · derivative · entry 3 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock · 75 shares Expires 2032-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 15:44 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 26 | $85.00 | $2,210.00 |
DisclosureSEC source: 0001127602-24-009313 · form4.xml · nonDerivative · entry 2 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 957.057 Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 15:44 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009313 · form4.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 983.057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:24 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 18,988 | $0.00 Strike: $79.95 | $0.00 |
DisclosureSEC source: 0001127602-24-008529 · form4.xml · derivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,988 Underlying: Common Stock · 18,988 shares Expires 2034-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| December 31, 2023 Filed Feb 5, 2024 23:28 UTC | CONMED Corp CNMD · Entity 4691 | Other401 (K) Plan | 18.243 | $109.51 | $1,997.79 |
DisclosureSEC source: 0001127602-24-003433 · form5.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Indirect · 401 (K) Plan Disclosed balance after: 70.613 F1 · date: As of 12/31/23. Read SEC document |
| June 17, 2023 Filed Jun 21, 2023 22:35 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-019194 · form4.xml · derivative · entry 3 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2029-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| June 17, 2023 Filed Jun 21, 2023 22:35 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 71 | $135.64 | $9,630.44 |
DisclosureSEC source: 0001127602-23-019194 · form4.xml · nonDerivative · entry 2 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 908.057 Read SEC document |
| June 17, 2023 Filed Jun 21, 2023 22:35 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-019194 · form4.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 979.057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 16:22 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 75 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-009539 · form4.xml · derivative · entry 3 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225 Underlying: Common Stock · 75 shares Expires 2032-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 16:22 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 26 | $95.32 | $2,478.32 |
DisclosureSEC source: 0001127602-23-009539 · form4.xml · nonDerivative · entry 2 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 729.057 Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 16:22 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-009539 · form4.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 755.057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:17 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 12,317 | $0.00 Strike: $96.16 | $0.00 |
DisclosureSEC source: 0001127602-23-008921 · form4.xml · derivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,317 Underlying: Common Stock · 12,317 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| October 03, 2022 Filed Feb 10, 2023 23:44 UTC | CONMED Corp CNMD · Entity 4691 | OtherCommon Stock | 1.32 | $81.63 | $107.75 |
DisclosureSEC source: 0001127602-23-004576 · form5.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 680.057 Read SEC document |
| June 30, 2022 Filed Jul 7, 2022 19:28 UTC | CONMED Corp CNMD · Entity 4691 | OtherCommon Stock | 0.737 | $97.69 | $72.00 |
DisclosureSEC source: 0001127602-22-019039 · form4.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 678.737 F1 · kind: The acquisition was pursuant to a written plan. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 01:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017957 · form4.xml · derivative · entry 3 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2029-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 01:55 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 72 | $88.93 | $6,402.96 |
DisclosureSEC source: 0001127602-22-017957 · form4.xml · nonDerivative · entry 2 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 678 Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 01:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017957 · form4.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.